SURGICAL OUTCOMES OF LAPAROSCOPIC HEPATECTOMY FOR HEPATOCELLULAR CARCINOMA: A SINGLE-CENTER EXPERIENCE
Main Article Content
Abstract
Objective: To evaluate the outcomes of laparoscopic hepatectomy in the treatment of hepatocellular carcinoma at a single center.
Methods: A descriptive study with retrospective and prospective data collection was conducted on 280 patients with hepatocellular carcinoma who underwent laparoscopic hepatectomy at Nghe An Oncology Hospital from January 2020 to May 2025. Variables included clinical characteristics, liver function (Child-Pugh classification), AFP levels, surgical characteristics, intraoperative and postoperative complications, length of hospital stay, and overall survival. Data were collected from medical records and postoperative follow-up and analyzed using SPSS 22.0.
Results: The mean age was 65.2 ± 14.3 years, with a male-to-female ratio of 3.2:1. Most patients had Child-Pugh A liver function (96.8%), and AFP levels were mainly between 20-400 ng/mL (47.5%). Pure laparoscopic hepatectomy was performed in 93.9% of cases. Minor hepatectomy accounted for 60.3%, with posterior sectionectomy being the most common (16.7%). Major hepatectomy accounted for 39.5%, including left hepatectomy (19.3%), right hepatectomy (13.9%), and central hepatectomy (6.9%). The mean operative time was 116 ± 35.7 minutes, and the mean blood loss was 235 ± 73 mL. The rates of no complications were high both intraoperatively (94.7%) and postoperatively (92.5%), with bile leakage being the most common postoperative complication (3.2%). The mean hospital stay was 7.8 ± 1.4 days. The mean overall survival was 46.8 ± 1.5 months.
Conclusion: Laparoscopic hepatectomy is a safe and feasible procedure with favorable outcomes for hepatocellular carcinoma and can be effectively applied in experienced centers with appropriate patient selection
Article Details
Keywords
Laparoscopic hepatectomy, hepatocellular carcinoma, minimally invasive surgery, surgical outcomes.
References
[2] Yang J.D, Hainaut P, Gores G.J, Amadou A, Plymoth A, Roberts L.R. A global view of hepatocellular carcinoma: trends, risk, prevention and management. Nat Rev Gastroenterol Hepatol, 2019, 16 (10): 589-604. doi: 10.1038/s41575-019-0186-y
[3] Bộ Y tế. Hướng dẫn chẩn đoán và điều trị ung thư biểu mô tế bào gan (Ban hành kèm theo Quyết định số 3129/QĐ-BYT, ngày 17 tháng 7 năm 2020).
[4] Park M.S, Cho J.Y, Kim E et al. Surgical treatment of hepatocellular carcinoma: an expert consensus-based practical recommendation from the Korean Liver Cancer Association. J Liver Cancer, 2025, 25 (2): 140-159. doi: 10.17998/jlc.2025.08.05
[5] Cassese G, Giannone F, Cipriani F et al. Laparoscopic versus open liver resection for huge hepatocellular carcinoma (≥ than 10 cm): a multicenter propensity score-matched analysis from Eastern and Western referral centers. Surg Endosc, 2026, 40 (4): 3151-3157. doi: 10.1007/s00464-026-12597-9
[6] Peng Y, Liu F, Xu H, Lan X, Wei Y, Li B. Outcomes of laparoscopic liver resection for patients with multiple hepatocellular carcinomas meeting the Milan criteria: a propensity score-matched analysis. J Laparoendosc Adv Surg Tech A. 2019; 29 (9): 1144-1151. doi: 10.1089/lap.2019.0362
[7] Hồ Văn Linh, Hồ Võ Hoài Phương, Đặng Quốc Ái. Kết quả phẫu thuật nội soi cắt gan. Tạp chí Y học Việt Nam, 2025, 551 (1): 33-37. doi:1 0.51298/vmj.v551i1.14447
[8] Amin N, Anwar J, Sulaiman A, Naumova N.N, Anwar N. Hepatocellular carcinoma: a comprehensive review. Diseases, 2025, 13 (7): 207. doi: 10.3390/diseases13070207
[9] Elderkin J, Al Hallak N, Azmi A.S et al. Hepatocellular carcinoma: surveillance, diagnosis, evaluation and management. Cancers, 2023, 15 (21): 5118. doi: 10.3390/cancers15215118
[10] Liu Y, Jiang W, Li X, Zhao H, Wang S. The diagnostic performance of AFP, AFP-L3, DCP, CA199, and their combination for primary liver cancer. J Hepatocell Carcinoma, 2025, 12: 513-526. doi: 10.2147/JHC.S499966